Reuters logo
BRIEF-Mirati Therapeutics Q1 loss per share $0.73
2017年5月4日 / 晚上8点46分 / 4 个月前

BRIEF-Mirati Therapeutics Q1 loss per share $0.73

May 4 (Reuters) - Mirati Therapeutics Inc:

* Mirati Therapeutics - expect currently available cash, cash equivalents and short-term investments sufficient to fund operations into late 2018

* Mirati Therapeutics reports first quarter 2017 financial results

* Q1 loss per share $0.73

* Q1 earnings per share view $-0.79 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below